Generic Pharmaceutical Business Investment Opportunities in Palghar

Pharmaceutical company engaged in generic drug development, manufacturing, and global product commercialization. - Offers a wide portfolio including oral dosage forms, semi-solids, and sterile injectables with end-to-end capabilities. - Also involved in niche API development, expanding presence across both formulations and active ingredients. - Holds 125+ marketing authorizations (MAs) and registrations globally, including 50+ in regulated markets (excluding the US). - Developed 200+ generic formulations and 20+ APIs, demonstrating strong R&D capabilities and product depth. - Maintains supply agreements for 100+ products, ensuring recurring revenue and long-term client engagement. - Supplies to premium pharmaceutical companies across Europe, UK, Australia, and New Zealand. - Owns valuable intellectual property across multiple products and markets, strengthening competitive positioning. - Operates a WHO-GMP approved API manufacturing facility, ensuring compliance with global quality standards. - Provides regulatory and quality consultancy services for advanced market approvals. - Utilizes contract workforce for flexible and efficient operations. - Positioned as a global generics player with strong regulatory footprint and expansion potential into new markets.

Pharmaceutical company engaged in generic drug development, manufacturing, and global product commercialization. - Offers a wide portfolio including oral dosage forms, semi-solids, and sterile injectables with end-to-end capabilities. - Also involved in niche API development, expanding presence across both formulations and active ingredients. - Holds 125+ marketing authorizations (MAs) and registrations globally, including 50+ in regulated markets (excluding the US). - Developed 200+ generic formulations and 20+ APIs, demonstrating strong R&D capabilities and product depth. - Maintains supply agreements for 100+ products, ensuring recurring revenue and long-term client engagement. - Supplies to premium pharmaceutical companies across Europe, UK, Australia, and New Zealand. - Owns valuable intellectual property across multiple products and markets, strengthening competitive positioning. - Operates a WHO-GMP approved API manufacturing facility, ensuring compliance with global quality standards. - Provides regulatory and quality consultancy services for advanced market approvals. - Utilizes contract workforce for flexible and efficient operations. - Positioned as a global generics player with strong regulatory footprint and expansion potential into new markets.